Civik Thomas
SEC CIK 1723092 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Dir | 206.2K | $200.0K | — | 3 | 2021-11-18 | 2023-03-24 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Civik Thomas made no open-market trades at PYXS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Civik Thomas | Dir | A - Grant | $0.00 | +139.4K | 206.2K | +209% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Civik Thomas | Dir | A - Grant | $0.00 | +66.8K | 66.8K | New | $0 | |
| I | 2021-11-19 | 2021-11-18 | PYXS | Pyxis Oncology, Inc. | Civik Thomas | Dir | P - Purchase | $12.74 | +15.7K | 15.7K | New | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations